Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sex Cord-Gonadal Stromal Tumors | 3 | 2023 | 105 | 1.740 |
Why?
|
Solitary Fibrous Tumors | 2 | 2022 | 72 | 1.540 |
Why?
|
Uterine Neoplasms | 3 | 2023 | 1513 | 1.360 |
Why?
|
Ovarian Neoplasms | 8 | 2023 | 4839 | 1.100 |
Why?
|
Granulosa Cell Tumor | 2 | 2023 | 71 | 1.070 |
Why?
|
Thecoma | 1 | 2023 | 11 | 0.920 |
Why?
|
Sertoli Cell Tumor | 1 | 2023 | 40 | 0.890 |
Why?
|
Endometrial Stromal Tumors | 1 | 2023 | 44 | 0.860 |
Why?
|
Adenosarcoma | 1 | 2022 | 34 | 0.850 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2023 | 91 | 0.840 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2022 | 102 | 0.800 |
Why?
|
Peritoneum | 1 | 2022 | 228 | 0.790 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2022 | 450 | 0.780 |
Why?
|
Fibroma | 1 | 2021 | 212 | 0.710 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 241 | 0.710 |
Why?
|
Endometrial Neoplasms | 3 | 2023 | 1351 | 0.680 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 44 | 0.650 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2018 | 99 | 0.630 |
Why?
|
Cell Transformation, Viral | 1 | 2019 | 567 | 0.630 |
Why?
|
Leiomyoma | 1 | 2023 | 730 | 0.600 |
Why?
|
Ovary | 1 | 2021 | 981 | 0.580 |
Why?
|
Testicular Neoplasms | 1 | 2023 | 806 | 0.570 |
Why?
|
Genital Neoplasms, Female | 1 | 2022 | 523 | 0.560 |
Why?
|
Nose Neoplasms | 1 | 2018 | 246 | 0.560 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2023 | 2020 | 0.550 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 665 | 0.550 |
Why?
|
Mesothelioma | 1 | 2022 | 818 | 0.540 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2018 | 776 | 0.490 |
Why?
|
Papillomaviridae | 2 | 2023 | 1119 | 0.490 |
Why?
|
Endometriosis | 1 | 2022 | 839 | 0.480 |
Why?
|
Papillomavirus Infections | 2 | 2023 | 1587 | 0.400 |
Why?
|
Sinusitis | 1 | 2018 | 923 | 0.350 |
Why?
|
Diagnosis, Differential | 5 | 2022 | 12961 | 0.330 |
Why?
|
Immunohistochemistry | 4 | 2023 | 11366 | 0.310 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2736 | 0.260 |
Why?
|
Cervix Uteri | 3 | 2023 | 590 | 0.250 |
Why?
|
Sclerosis | 1 | 2023 | 213 | 0.220 |
Why?
|
Papilloma | 1 | 2023 | 148 | 0.220 |
Why?
|
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1 | 2021 | 10 | 0.210 |
Why?
|
14-3-3 Proteins | 1 | 2023 | 214 | 0.210 |
Why?
|
Isochromosomes | 1 | 2021 | 16 | 0.210 |
Why?
|
Cyclin D1 | 1 | 2023 | 463 | 0.190 |
Why?
|
Cyclin E | 1 | 2021 | 172 | 0.190 |
Why?
|
Diaphragm | 1 | 2022 | 349 | 0.190 |
Why?
|
Carcinoma, Endometrioid | 1 | 2023 | 271 | 0.190 |
Why?
|
Ribonuclease III | 1 | 2022 | 275 | 0.190 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2023 | 705 | 0.180 |
Why?
|
Endometrium | 1 | 2023 | 424 | 0.180 |
Why?
|
Orchiectomy | 1 | 2022 | 474 | 0.180 |
Why?
|
DEAD-box RNA Helicases | 1 | 2022 | 375 | 0.170 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2022 | 449 | 0.170 |
Why?
|
BRCA2 Protein | 2 | 2021 | 794 | 0.170 |
Why?
|
Platinum | 1 | 2020 | 233 | 0.170 |
Why?
|
Female | 17 | 2023 | 380193 | 0.160 |
Why?
|
Prognosis | 4 | 2023 | 29060 | 0.150 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13104 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2023 | 4034 | 0.150 |
Why?
|
Oncogene Proteins | 1 | 2021 | 749 | 0.150 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 501 | 0.140 |
Why?
|
Gene Dosage | 1 | 2021 | 1252 | 0.140 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2023 | 2649 | 0.140 |
Why?
|
Mutation | 2 | 2021 | 29786 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9240 | 0.120 |
Why?
|
Humans | 19 | 2023 | 744366 | 0.120 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15078 | 0.110 |
Why?
|
Biological Products | 1 | 2021 | 860 | 0.110 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2021 | 2455 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 1 | 2022 | 2850 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2019 | 1480 | 0.090 |
Why?
|
Epithelial Cells | 1 | 2022 | 3690 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3464 | 0.090 |
Why?
|
Adult | 9 | 2023 | 214052 | 0.090 |
Why?
|
Pelvis | 2 | 2023 | 730 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17446 | 0.080 |
Why?
|
Biopsy | 1 | 2018 | 6755 | 0.070 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1879 | 0.070 |
Why?
|
Mice, SCID | 2 | 2021 | 2716 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5172 | 0.070 |
Why?
|
Models, Biological | 1 | 2021 | 9584 | 0.060 |
Why?
|
Aged | 6 | 2023 | 163288 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5534 | 0.060 |
Why?
|
Middle Aged | 6 | 2023 | 213390 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9145 | 0.060 |
Why?
|
Young Adult | 4 | 2023 | 56429 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3554 | 0.050 |
Why?
|
Rete Testis | 1 | 2022 | 9 | 0.050 |
Why?
|
Tumor Stem Cell Assay | 1 | 2021 | 118 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16367 | 0.050 |
Why?
|
Risk Assessment | 1 | 2022 | 23336 | 0.050 |
Why?
|
S Phase | 1 | 2021 | 423 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39052 | 0.050 |
Why?
|
Rad51 Recombinase | 1 | 2020 | 189 | 0.040 |
Why?
|
Pennsylvania | 1 | 2021 | 613 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11525 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1185 | 0.040 |
Why?
|
Neoplasm Staging | 2 | 2023 | 11031 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 889 | 0.040 |
Why?
|
Cyclins | 1 | 2020 | 603 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2023 | 1262 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 808 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13693 | 0.040 |
Why?
|
Adolescent | 2 | 2021 | 85779 | 0.040 |
Why?
|
Gender Identity | 1 | 2022 | 687 | 0.040 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1788 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2023 | 2924 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2023 | 3616 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 1958 | 0.030 |
Why?
|
DNA Replication | 1 | 2021 | 1399 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9724 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16690 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1149 | 0.030 |
Why?
|
Child | 1 | 2021 | 77709 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2023 | 2949 | 0.030 |
Why?
|
Cell Survival | 1 | 2021 | 5882 | 0.020 |
Why?
|
Bone Marrow | 1 | 2021 | 2948 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4851 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77460 | 0.020 |
Why?
|
Male | 2 | 2023 | 350115 | 0.020 |
Why?
|
Stem Cells | 1 | 2020 | 3567 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20952 | 0.020 |
Why?
|
Animals | 2 | 2021 | 168768 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 57776 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23404 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81201 | 0.010 |
Why?
|
Concepts
(124)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_